NEW YORK (GenomeWeb News) – RainDance Technologies said today that it has signed the J. Craig Venter Institute as an early-access partner for its microfluidics-based sequence-enrichment technology for next-generation sequencing.
 
Under the terms of the agreement, JCVI will have access to the company’s RDT 1000 instrument and Sequence Enrichment application, which are based on RainDance's RainStorm droplet-based technology platform.
 

To read the full story....

Register for Free.

Already have a GenomeWeb or 360Dx account?
Login Now.

CNN reports that researchers have tied a new variant to opioid addiction risk.

Organoids derived from patients' tumors may help determine what chemotherapy treatment patients would benefit from, according to New Scientist.

An initiative from GenomeAsia 100K hopes to increase the number of South Asians in genetic research, according to NBC News.

In Science this week: genomic analysis of ancient and modern horses indicates population turnover, and more.